Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Scanlon

Showing results (161-170 of 570) with videos related to

Pageof 57
Sort By:
Sozial- Und Praventivmedizin|December 29, 2006
A programme for Health Impact Assessment in Brighton and HoveThomas J Scanlon, Lydie Lawrence, Terry Blair-Stevens, et al.
Journal of Electrocardiology|July 1, 1992
The clinical significance of exercise-induced bundle branch blockJ F Moran, B Scurlock, R Henkin, et al.
Surgical Endoscopy|April 19, 2002
Selection criteria among gastroenterologists and surgeons for laparoscopic antireflux surgeryB Sarani, J Scanlon, P Jackson, et al.
Carcinogenesis|September 1, 1994
Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacityP Taverna, J Hansson, K J Scanlon, et al.
The Journal of Investigative Dermatology|February 1, 1996
Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymesY Ohta, H Kijima, M Kashani-Sabet, et al.
The Biochemical Journal|June 26, 2025
Methods to accelerate PROTAC drug discoveryJeyan Osman, Philip E Thompson, Manuela Jörg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cellsK J Scanlon, E M Newman, Y Lu, et al.
Gene Therapy|February 15, 2001
Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude miceY A Zhang, J Nemunaitis, K J Scanlon, et al.
Molecules (Basel, Switzerland)|July 21, 2016
Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence AgentsRoxanne P Smith, Jason J Paxman, Martin J Scanlon, et al.
Circulation|August 1, 1990
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular functionD J Wilber, B Olshansky, J F Moran, et al.
Pageof 57

Showing results (161-170 of 570) with videos related to

Sort By:
Pageof 57
Sozial- Und Praventivmedizin|December 29, 2006
A programme for Health Impact Assessment in Brighton and HoveThomas J Scanlon, Lydie Lawrence, Terry Blair-Stevens, et al.
Journal of Electrocardiology|July 1, 1992
The clinical significance of exercise-induced bundle branch blockJ F Moran, B Scurlock, R Henkin, et al.
Surgical Endoscopy|April 19, 2002
Selection criteria among gastroenterologists and surgeons for laparoscopic antireflux surgeryB Sarani, J Scanlon, P Jackson, et al.
Carcinogenesis|September 1, 1994
Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacityP Taverna, J Hansson, K J Scanlon, et al.
The Journal of Investigative Dermatology|February 1, 1996
Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymesY Ohta, H Kijima, M Kashani-Sabet, et al.
The Biochemical Journal|June 26, 2025
Methods to accelerate PROTAC drug discoveryJeyan Osman, Philip E Thompson, Manuela Jörg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cellsK J Scanlon, E M Newman, Y Lu, et al.
Gene Therapy|February 15, 2001
Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude miceY A Zhang, J Nemunaitis, K J Scanlon, et al.
Molecules (Basel, Switzerland)|July 21, 2016
Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence AgentsRoxanne P Smith, Jason J Paxman, Martin J Scanlon, et al.
Circulation|August 1, 1990
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular functionD J Wilber, B Olshansky, J F Moran, et al.
Pageof 57